|58.67||-1.16||-1.94%||Vol 363.11K||1Y Perf 70.52%|
|Apr 19th, 2021 16:00 DELAYED|
|- -||- -%|
|Target Price||65.89||Analyst Rating||Strong Buy 1.13|
|Potential %||12.31||Finscreener Ranking||★★★★ 55.29|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★★★ 52.54|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★★ 53.88|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||— -|
|Market Cap||2.44B||Earnings Rating||Strong Sell|
|Price Range Ratio 52W %||92.01||Earnings Date||6th May 2021|
Today's Price Range
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||6th May 2021|
|Estimated EPS Next Report||-0.41|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||361.36K|
|Avg. Monthly Volume||443.43K|
|Avg. Quarterly Volume||569.08K|
Axonics Modulation Technologies Inc. (NASDAQ: AXNX) stock closed at 58.67 per share at the end of the most recent trading day (a -1.94% change compared to the prior day closing price) with a volume of 363.15K shares and market capitalization of 2.44B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 302 people. Axonics Modulation Technologies Inc. CEO is Raymond Wayne Cohen.
The one-year performance of Axonics Modulation Technologies Inc. stock is 70.52%, while year-to-date (YTD) performance is 17.53%. AXNX stock has a five-year performance of %. Its 52-week range is between 30 and 61.16, which gives AXNX stock a 52-week price range ratio of 92.01%
Axonics Modulation Technologies Inc. currently has a PE ratio of -40.20, a price-to-book (PB) ratio of 8.66, a price-to-sale (PS) ratio of 28.63, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -18.89%, a ROC of -29.73% and a ROE of -22.57%. The company’s profit margin is -46.99%, its EBITDA margin is -72.40%, and its revenue ttm is $85.24 Million , which makes it $2.05 revenue per share.
Of the last four earnings reports from Axonics Modulation Technologies Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.41 for the next earnings report. Axonics Modulation Technologies Inc.’s next earnings report date is 06th May 2021.
The consensus rating of Wall Street analysts for Axonics Modulation Technologies Inc. is Strong Buy (1.13), with a target price of $65.89, which is +12.31% compared to the current price. The earnings rating for Axonics Modulation Technologies Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Axonics Modulation Technologies Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Axonics Modulation Technologies Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 8.87, ATR14 : 2.82, CCI20 : 17.42, Chaikin Money Flow : 0.17, MACD : 1.74, Money Flow Index : 54.93, ROC : -2.04, RSI : 52.05, STOCH (14,3) : 62.95, STOCH RSI : 0.00, UO : 65.10, Williams %R : -37.05), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Axonics Modulation Technologies Inc. in the last 12-months were: Alfred J. Ford (Option Excercise at a value of $49 700), Alfred J. Ford (Sold 41 967 shares of value $1 747 389 ), Danny L. Dearen (Option Excercise at a value of $217 927), Danny L. Dearen (Sold 182 508 shares of value $6 955 513 ), John Woock (Option Excercise at a value of $20 800), John Woock (Sold 33 810 shares of value $1 662 275 ), Juliet Tammenoms Bakker (Sold 13 953 shares of value $597 963 ), Raymond Wayne Cohen (Option Excercise at a value of $0), Raymond Wayne Cohen (Sold 166 469 shares of value $6 907 656 ), Rinda Sama (Option Excercise at a value of $456 585), Rinda Sama (Sold 154 162 shares of value $6 738 123 ), Robert E. Mcnamara (Sold 9 167 shares of value $475 133 )
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.